Clinical Edge Journal Scan

Clinical Edge Journal Scan

Simultaneous integrated boost noninferior to sequential boost in phase 3 in early BC

• Read More

Clinical Edge Journal Scan

HR+/ERBB2+ early BC: Excellent pCR rate with de-escalated neoadjuvant paclitaxel plus trastuzumab and pertuzumab

• Read More

Clinical Edge Journal Scan

Phase 3 shows promising activity of capivasertib-fulvestrant combo in HR+/HER2− advanced BC

• Read More

Clinical Edge Journal Scan

Commentary: Pregnancy, neoadjuvant treatment, and sexual function after BC diagnosis, June 2023

Author:

Erin Roesch, MD

• Read More

Clinical Edge Journal Scan

Reproductive tract infections associated with lower risk and better prognosis in breast cancer

• Read More

Clinical Edge Journal Scan

Breast cancer survivors face increased risk for sexual dysfunction

• Read More

Clinical Edge Journal Scan

Are family members of early-onset BC patients at risk for discordant early-onset cancers?

• Read More

Clinical Edge Journal Scan

Anlotinib-chemotherapy combo shows good efficacy and safety in metastatic TNBC

• Read More

Clinical Edge Journal Scan

¹²⁵I seed placement before neoadjuvant chemotherapy good marking method for metastatic lymph nodes in BC

• Read More

Clinical Edge Journal Scan

HER2+ early BC: Extent of disease at diagnosis may predict risk for relapse even after pCR

• Read More

Clinical Edge Journal Scan

Postmastectomy implants did not increase risk for squamous cell carcinoma in BC patients

• Read More